"compound 12"
selective GluN2B negative allosteric mod. active in brain, proj. oral dose of 120 mg from cell-based HTS and opt. J. Med. Chem., Jul. 31, 2020 Janssen R&D, San Diego, CA
Molecules of the Month - August 2020
Molecules of the Month
- GS-6207
- PF-06826647
- MSA-2
- SR-717
- Vixotrigine (BIIB074)
- BI-3406
- "compound 3d"
- "compound 12" (GlaxoSmithKline)
- "compound 12j"
- "compound 7f"
- DS34942424
- "compound 12"
- "compound 37"
- "compound 20"